Don’t send a generic resume — generate a resume and cover letter tailored to this exact role.
Definium Therapeutics seeks a high-impact Head of Sales Training to own end-to-end strategy and execution for a novel CNS product, requiring deep scientific fluency, patient and HCP engagement, and strict compliance. You will influence launch readiness, field capability, and long-term commercial performance.
This role is fully remote in the U.S. with significant travel; a substantial portion of training delivery occurs near our Philadelphia office, and hybrid collaboration across Commercial,
Definium Therapeutics is a late-stage clinical biopharmaceutical company and our mission is to forge a new era of psychiatry by applying scientific rigor to psychedelics, with the goal of developing accessible treatments that unlock healing at scale.
Our lead product candidate, lysergide tartrate (our proprietary orally disintegrating tablet form of lysergide (LSD) D-tartrate), represents a highly differentiated, potential best-in-class opportunity for patients suffering from generalized anxiety, major depressive disorder, and posttraumatic stress disorder. Our early stage pipeline includes DT402, the R-enantiomer of MDMA and is under development to target the core symptoms of autism spectrum disorder (ASD), specifically addressing social communication challenges.
Guided by the recognition that patients deserve more than better, Definium is relentlessly advancing a new generation of therapeutics intended to address the underlying causes of psychiatric and neurological disorders. By turning evidence into impact, Definium aims to change the trajectory of today’s mental health care crisis and enable a healthier future. Headquartered in New York, Definium Therapeutics trades on Nasdaq under the symbol DFTX.
Together we are moving psychiatry forward—beyond better, into a boundless future. Join us!
This is a high-impact, foundational leadership role reporting to the VP of Sales. You will own the end-to-end strategy and execution of sales training and capability development for a novel CNS product that will require deep scientific fluency, nuanced patient and HCP engagement, and rigorous compliance. You will shape how our future sales organization and adjacent commercial field teams master the science, the patient journey, competitive differentiation, and the unique considerations of bringing a novel psychedelic therapy to market. Success in this role will directly influence launch readiness, field force excellence, and long-term commercial performance.
Location: Fully remote within the U.S., with frequent travel required. A significant portion of training delivery and team collaboration will occur at our Philadelphia office; therefore, candidates based in or near the Philadelphia area are strongly preferred.
Compensation will be determined based on several factors including, but not limited to, skill set, years of experience, and the employee’s geographic location.
Employees in this role may be entitled to additional compensation, including bonus and equity. Benefits information is listed on our Jobs Page. The Company provides competitive benefits to employees including:
The starting base pay range for this position:
$250,000 - $280,000 USD